US equities
|
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Caribou Biosciences, Inc. - Common Stock
(NQ:
CRBU
)
0.5600
+0.0156 (+2.87%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Caribou Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Caribou Biosciences Announces FDA Granted Fast Track Designation to CB-011, an Allogeneic CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma
April 04, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PLDT, Global Payments, Caribou, and Inspirato and Encourages Investors to Contact the Firm
April 02, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBU
April 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
HC Wainwright & Co. Maintains Buy Rating for Caribou Biosciences: Here's What You Need To Know
↗
March 14, 2023
Via
Benzinga
Caribou Biosciences Initiates Dose Expansion Portion of CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients
March 29, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences Announces Dosing of First Patient in the CaMMouflage Phase 1 Trial of CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma
March 29, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
March 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action - CRBU
March 27, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Atlassian, PLDT, Global Payments, and Caribou and Encourages Investors to Contact the Firm
March 22, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
March 22, 2023
WHY: New York, NY - (NewMediaWire) - March 22, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Caribou Biosciences, Inc. (NASDAQ: CRBU): (i) pursuant...
Via
NewMediaWire
Topics
Lawsuit
CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Caribou Biosciences, Inc. (NASDAQ: CRBU)
March 20, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
March 19, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
March 17, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Caribou Biosciences, Inc. (NASDAQ: CRBU)
March 13, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Global Payments, Caribou, Inspirato, and Kornit and Encourages Investors to Contact the Firm
March 12, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
March 12, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 10, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
March 10, 2023
We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday!
Via
InvestorPlace
Caribou Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 09, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Caribou Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
March 08, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Global Payments, Caribou, Inspirato, and Kornit and Encourages Investors to Contact the Firm
March 06, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
March 06, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Caribou Biosciences, Inc. (NASDAQ: CRBU)
March 06, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
March 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
March 01, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
NASDAQ: CRBU Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Caribou Biosciences, Inc.
↗
February 28, 2023
San Diego, CA -- (SBWIRE) -- 02/28/2023 -- An investor, who purchased shares of Caribou Biosciences, Inc. (NASDAQ: CRBU), filed a lawsuit over alleged violations of Federal Securities Laws by Caribou...
Via
SBWire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
February 26, 2023
WHY: New York, NY - (NewMediaWire) - February 26, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Caribou Biosciences, Inc. (NASDAQ: CRBU): (i) pursuant...
Via
NewMediaWire
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Caribou, Inspirato, Kornit, and Alico and Encourages Investors to Contact the Firm
February 24, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING AND RANKED FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
February 23, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Caribou Biosciences, Inc. (CRBU) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Caribou Biosciences, Inc.
February 22, 2023
From
Robbins LLP
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
